A Study of Bevacizumab Therapy in Patients With Newly Diagnosed High-Grade Gliomas and Diffuse Intrinsic Pontine Gliomas

NCT00890786 · clinicaltrials.gov ↗

EARLY_PHASE1

Phase

COMPLETED

Status

27

Enrollment

OTHER

Sponsor class

Conditions

Newly Diagnosed High-Grade Gliomas
Diffuse Intrinsic Pontine Glioma

Interventions

DRUG: Temozolomide
DRUG: Bevacizumab
DRUG: Irinotecan

Sponsor

Children's Hospital Medical Center, Cincinnati

Collaborators

[object Object]